

Value added medicines are therapies where innovation has been applied around an off-patent molecule, for example by reformulation or applying a device.
Download the executive summary of the webinar ‘A Patient-Centric Approach to Digital Value Added Medicines’, presented by Aurelio Arias, Engagement Manager, Thought Leadership, IQVIA, and hosted by Generics Bulletin, to learn more about the drivers associated with value added medicine, as well as the challenges and future trends associated with this sector.
You can also listen to the recorded webinar by clicking here